The COX-2-1195AA Genotype Is Associated with Diffuse-Type Gastric Cancer in Korea

被引:21
|
作者
Shin, Woon Geon [1 ]
Kim, Ha Jung [2 ]
Cho, Sung Jin [3 ]
Kim, Hyoung Su [1 ]
Kim, Kyung Ho [1 ]
Jang, Myoung Kuk [1 ]
Lee, Jin Heon [1 ]
Kim, Hak Yang [1 ]
机构
[1] Hallym Univ, Coll Med, Dept Internal Med, Seoul 134701, South Korea
[2] Hallym Univ, Coll Med, Lab Study Gastroenterol & Hepatol, Seoul 134701, South Korea
[3] Hallym Univ, Coll Med, Dept Pathol, Seoul 134701, South Korea
关键词
Stomach neoplasms; Diffuse type; COX-2; Polymorphism; HELICOBACTER-PYLORI INFECTION; E-CADHERIN GENE; ATROPHIC GASTRITIS; CYCLOOXYGENASE-2; EXPRESSION; INTESTINAL METAPLASIA; GERMLINE MUTATIONS; INCREASED RISK; POLYMORPHISMS; CARCINOGENESIS; INTERLEUKIN-1;
D O I
10.5009/gnl.2012.6.3.321
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: The potential role of the cyclooxygenase (COX)-2 polymorphism has been reported in relation to the risk of gastrointestinal tract malignancies. Therefore, we investigated whether COX-2 polymorphisms are associated with the risk of gastric cancer (GC) in Korea, one of the areas with a high prevalence of this condition. Methods: We evaluated the genotypic frequencies of COX-2-765 and -1195 in 100 peptic ulcer patients, 100 GC patients, and 100 healthy controls. The polymorphisms of the COX-2-765 and -1195 genes were analyzed by polymerase chain reaction and restriction fragment length polymorphisms. Results: The frequencies of the COX-2-1195 GG, GA, and AA genotype were 20%, 60%, and 20% in intestinal-type GC and 8%, 48%, and 44% in diffuse-type GC, respectively (p=0.021). There were no significant differences in the frequency of COX-2-765 genotypes between intestinal-type GC and diffuse-type GC (p=0.603). Age- and sex-adjusted logistic regression analysis showed that the COX-2-1195 AA genotype was the independent risk factor of diffuse-type GC compared with the COX-2-1195 GG genotype (p=0.041; odds ratio, 6.22; 95% confidence interval, 1.077 to 35.870). Conclusions: The COX-2-1195 M genotype may render subjects more susceptible to diffuse-type GC. (Gut Liver 2012;6:321-327)
引用
收藏
页码:321 / 327
页数:7
相关论文
共 50 条
  • [1] Role of Serum Pepsinogen II and Helicobacter pylori Status in the Detection of Diffuse-Type Early Gastric Cancer in Young Individuals in South Korea
    Baek, Sung Min
    Kim, Nayoung
    Kwon, Young Jae
    Lee, Hye Seung
    Kim, Hyun Young
    Lee, Jaebong
    Yoon, Hyuk
    Shin, Cheol Min
    Park, Young Soo
    Lee, Dong Ho
    GUT AND LIVER, 2020, 14 (04) : 439 - 449
  • [2] Bioinformatics analysis identifies biomarkers associated with poor prognosis in diffuse-type gastric cancer
    Li, Sheng
    Yu, Chao
    Cheng, Yuanguang
    Du, Fangchao
    Wen, Gang
    MOLECULAR MEDICINE REPORTS, 2021, 23 (03)
  • [3] A proteomic landscape of diffuse-type gastric cancer
    Ge, Sai
    Xia, Xia
    Ding, Chen
    Zhen, Bei
    Zhou, Quan
    Feng, Jinwen
    Yuan, Jiajia
    Chen, Rui
    Li, Yumei
    Ge, Zhongqi
    Ji, Jiafu
    Zhang, Lianhai
    Wang, Jiayuan
    Li, Zhongwu
    Lai, Yumei
    Hu, Ying
    Li, Yanyan
    Li, Yilin
    Gao, Jing
    Chen, Lin
    Xu, Jianming
    Zhang, Chunchao
    Jung, Sung Yun
    Choi, Jong Min
    Jain, Antrix
    Liu, Mingwei
    Song, Lei
    Liu, Wanlin
    Guo, Gaigai
    Gong, Tongqing
    Huang, Yin
    Qiu, Yang
    Huang, Wenwen
    Shi, Tieliu
    Zhu, Weimin
    Wang, Yi
    He, Fuchu
    Shen, Lin
    Qin, Jun
    NATURE COMMUNICATIONS, 2018, 9
  • [4] Role of DNA Methylation in the Development of Diffuse-Type Gastric Cancer
    Yamamoto, Eiichiro
    Suzuki, Hiromu
    Takamaru, Hiroyuki
    Yamamoto, Hiroyuki
    Toyota, Minoru
    Shinomura, Yasuhisa
    DIGESTION, 2011, 83 (04) : 241 - 249
  • [5] The risk of diffuse-type gastric cancer following diagnosis with gastric precancerous lesions: a systematic review and meta-analysis
    Wang, John E.
    Kim, Sung Eun
    Lee, Bong Eun
    Park, Sungho
    Hwang, Joo Ha
    Huang, Robert J.
    CANCER CAUSES & CONTROL, 2022, 33 (02) : 183 - 191
  • [6] Soluble podoplanin as a biomarker in diffuse-type gastric cancer
    Takiguchi, Koichi
    Shoda, Katsutoshi
    Nakayama, Takashi
    Takahashi, Kazunori
    Saito, Ryo
    Yamamoto, Atsushi
    Furuya, Shinji
    Akaike, Hidenori
    Hosomura, Naohiro
    Kawaguchi, Yoshihiko
    Amemiya, Hidetake
    Kawaida, Hiromichi
    Inoue, Shingo
    Kono, Hiroshi
    Konishi, Hirotaka
    Otsuji, Eigo
    Ichikawa, Daisuke
    ONCOLOGY REPORTS, 2022, 47 (03)
  • [7] The dawn of precision medicine in diffuse-type gastric cancer
    Ooki, Akira
    Yamaguchi, Kensei
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [8] The Characteristics and Prognosis of Diffuse-Type Early Gastric Cancer Diagnosed during Health Check-Ups
    Lee, Ji Young
    Gong, Eun Jeong
    Chung, Eun Ju
    Park, Hye Won
    Bae, Suh Eun
    Kim, Eun Hee
    Kim, Jaeil
    Do, Yoon Suh
    Kim, Tae Hyup
    Chang, Hye-Sook
    Song, Ho June
    Choe, Jaewon
    Jung, Hwoon-Yong
    GUT AND LIVER, 2017, 11 (06) : 807 - 812
  • [9] RHOA mutation in diffuse-type gastric cancer: a comparative clinicopathology analysis of 87 cases
    Ushiku, Tetsuo
    Ishikawa, Shumpei
    Kakiuchi, Miwako
    Tanaka, Atsushi
    Katoh, Hiroto
    Aburatani, Hiroyuki
    Lauwers, Gregory Y.
    Fukayama, Masashi
    GASTRIC CANCER, 2016, 19 (02) : 403 - 411
  • [10] Decreased expression of the adhesion molecule desmoglein-2 is associated with diffuse-type gastric carcinoma
    Yashiro, Masakazu
    Nishioka, Nobuaki
    Hirakawa, Kosei
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (14) : 2397 - 2403